)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
China Resources Pharmaceutical Group
China Resources Pharmaceutical Group (3320) investor relations material
China Resources Pharmaceutical Group H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary24 Aug, 2026
Executive summary
Revenue rose 2.0% year-over-year to RMB134,457.6 million for the six months ended 30 June 2026, with net profit at RMB5,023.5 million, down 0.6% year-over-year.
Gross profit was RMB21,534.1 million, up 0.1% year-over-year, with a gross margin of 16.0%, down 0.3 percentage points.
Interim dividend declared at RMB0.087 per share, a 21% increase year-over-year.
The group maintained leading positions in pharmaceutical manufacturing and distribution, with strategic focus on R&D, digital transformation, and ESG.
Financial highlights
Revenue: RMB134,457.6 million (+2.0% YoY); Gross profit: RMB21,534.1 million (+0.1% YoY).
Net profit: RMB5,023.5 million (-0.6% YoY); Profit attributable to shareholders: RMB2,186.6 million (+5.3% YoY).
Basic EPS: RMB0.35 (vs. RMB0.33 prior year); Interim dividend: RMB0.087/share (vs. RMB0.072 prior year).
Gross margin: 16.0% (down 0.3 ppt YoY); Net cash from operating activities: RMB1,423.1 million.
Outlook and guidance
Focus on strategic emerging industries: biological drugs, blood products, high-end medical devices, synthetic biology.
Continued investment in R&D, digital transformation, and ESG initiatives.
Plans to strengthen operational excellence, smart manufacturing, and international expansion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from China Resources Pharmaceutical Group
- Net profit up 14.9% on 4.6% revenue growth, with improved margins and higher dividend.3320
H2 2025 - Revenue up 2.5% YoY, net profit down 8.8%, strong segment growth and innovation focus.3320H1 2025
- Revenue and net profit rose 10.2% with strong segment growth and first interim dividend declared.3320H1 2024
- Revenue and net profit rose, driven by strong pharma, R&D, and digital transformation.3320H2 2024
China Resources Pharmaceutical Group
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage